David Nielsen, Ph.D. studies the genetics and epigenetics of psychiatric diseases, including pharmacogenomics of the treatment of the addictions and vulnerability to develop addictions. He has worked in the field of psychiatric genetics for the last 20 years and has numerous publications. He has an extensive background in the genetics of addiction, molecular biology, and bioinformatics. Dr. Nielsen's research aims are the understanding the inter-individual differences in pharmacogenetic components that modulate therapeutic response of treatment of psychostimulant addiction and of vaccines for the treatment of addictions. Studies are underway investigating the genetic moderation of the subjective effects of cocaine, vulnerability to develop cocaine and nicotine addictions and bipolar disorder as well as recovery from traumatic brain injury (TBI). He also studies the epigenetics of addictive drugs, cocaine associated decreases in brain white matter integrity, TBI, and maternal behavior.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
Alcohol and Addiction Research
Gulf Coast Cluster for Translational Addiction Science
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.